CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Mycophenolate Mofetil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01672957
NCT01672957N/ACompleted

Non-interventional Clinical Study With Target of Kidney Function Follow-up in Routine Clinical Practice on De Novo Kidney Transplant Recipients Who Are on CellCept Immunosuppressive Combination Therapy in Routine Clinical Practice

Hoffmann-La Roche·observational·Posted Aug 27, 2012·Updated Oct 11, 2016

In Brief

An observational study evaluating Mycophenolate Mofetil and Immunosuppressive Therapy for Kidney Transplantation. Completed, enrolled 128 participants across 2 sites.

Detailed Summary

This observational study will evaluate renal function in participants who underwent renal allograft transplantation and are started on combined immunosuppressive treatment containing mycophenolate mofetil (CellCept). Eligible participants will be followed for 12 months following transplantation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesHungary
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 27, 2012
Enrollment StartSep 1, 2011
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 13.8 years ago

Interventions

Mycophenolate Mofetildrug

Protocol does not specify any regimen for treatment. The choice of treatment will be made prior to enrollment by the treating physician.

Immunosuppressive Therapydrug

Protocol does not specify any particular immunosuppressive drug and regimen for treatment. The choice of immunosuppressive therapy will be made prior to enrollment by the treating physician.